ArticleFrontiers in oncology2023

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial.

Michel Fabbro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.